metaLead Therapeutics

Zürich, Switzerland

metaLead Therapeutics is to develop this peptide as a next-generation Pb poisoning treatment.

$1.2M raised

May 2025

Seed

Biopharma Biotechnology Therapeutics

Top Investors

BioInnovation Institute Venture Kick UZH Life Sciences Fund

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about metaLead Therapeutics

How much funding has metaLead Therapeutics raised?

metaLead Therapeutics has raised $1.2M in total funding. The most recent round was Seed. The last funding was announced in May 2025.

Who are metaLead Therapeutics's investors?

metaLead Therapeutics's investors include BioInnovation Institute, Venture Kick, UZH Life Sciences Fund.

Where is metaLead Therapeutics headquartered?

metaLead Therapeutics is headquartered in Zürich, Switzerland.

What does metaLead Therapeutics do?

metaLead Therapeutics is to develop this peptide as a next-generation Pb poisoning treatment.

What stage is metaLead Therapeutics at?

metaLead Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 6, 2025.

MLA

"metaLead Therapeutics — Funding & Investors." VCBacked, May 6, 2025, https://www.vcbacked.co/company/metalead-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2025). metaLead Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/metalead-therapeutics

Wikipedia (cite web)

{{cite web |title=metaLead Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/metalead-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 6, 2025.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.